Novartis Pharmaceuticals Customer Success Manager Salaries in New York
The average Novartis Pharmaceuticals Customer Success Manager in New York earns an estimated $66,364 annually, which includes an estimated base salary of $57,639 with a $8,725 bonus. Novartis Pharmaceuticals' Customer Success Manager compensation is $14,575 more than the US average for a Customer Success Manager. Customer Success Manager salaries at Novartis Pharmaceuticals in New York can range from $34,560 - $80,000.
In New York, The Customer Support Department at Novartis Pharmaceuticals earns $23,192 more on average than the Admin Department.
Last updated 2 years ago.
- $57,639
- avg. base
- $8,725
- avg. bonus
Customer Success Manager Salaries at Novartis Pharmaceuticals
In New York, Customer Success Managers earn $2,891 more than CS Reps, and $8,444 less than Customer Service Managers.
Compensation at Novartis Pharmaceuticals by Department
In New York, The Customer Support Department averages $23,192 more than the Admin Department, and $9,805 less than the Design Department
Customer Success Manager Compensation by Gender (All Companies)
The average female Customer Success Manager at companies similar size to Novartis Pharmaceuticals reported making $42,803, while the average male Customer Success Manager at similar sized companies reported making $51,559.
Customer Success Manager Compensation by Ethnicity (All Companies)
The average Native American Customer Success Manager at companies similar size to Novartis Pharmaceuticals reported making $68,667, while the average African American/Black Customer Success Manager at similar sized companies reported making $38,012.
How Customer Success Managers at Novartis Pharmaceuticals Rate Their Compensation
The majority of Customer Success Managers at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Customer Success Managers at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
